Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy

This article was originally published here

The trial is enrolling adult epilepsy patients with temporal lobe onset, with or without secondary generalized seizures. A clinical feasibility study at St. Vincent’s Hospital Melbourne (published in The

The post Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply